Atlas Trials

Topical Ruxolitinib for the Treatment of Vitiligo

Clinical trial NCT02809976 · COMPLETED

Trial details

NCT number
NCT02809976
Sponsor
Tufts Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Vitiligo
Start date
2016-01-01
Primary completion
2017-01-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.